Member Info for Laura2022

Ralph pointed this out from July

Dr Nathalie Dupuy has joined its technical team as a Biosimulation scientist.

Nathalie holds a PhD in Neuroinformatics from the University of Edinburgh and an MSc in Biomedical Engineering from Imperial College, London. Nathalie has also completed courses in AI related disciplines including data science, machine learning and natural language processing.

Dr Jim Millen, CEO, commented “As it expands, Physiomics continues to attract fantastic young talent. Nathalie will be a great addition to the team and help increase our capacity and capability to address our pipeline of project opportunities.”.

I have just googled them and they were a huge company but lost millions, at their peak they were valued at over £300mln

PYC can maybe take up the baton of A.I in medicine

If he is chaining the session that must mean he is an important person onntjis matter and if he works for PYC too?

I take from this that he believes PYC can succeed where others have failed ?

Thankyou for the reply , that makes sense now

19 December 2022

IT Governance awarded G-Cloud 13 framework contract

GRC International Group PLC (AIM: GRC, "GRC" or "the Group"), the international governance, risk management and compliance company whose main business is cyber defence-in-depth, announces that its IT Governance business has been awarded a G-Cloud 13 framework contract to provide more than 100 of its products and services via the UK government's Digital Marketplace. This eliminates the need for its customers to go through a full tender process.

 

Launched in 2012, G-Cloud 13 is an online catalogue and the newest iteration of the G-Cloud framework, which is used by the UK public sector to identify and acquire a diverse range of cloud-based computing services

Suppliers of all sizes see it as critical to be involved in the G-Cloud framework, as it services the whole of the UK public sector, from the NHS to local authorities and everything in between. Over 52,000 listed organisations can purchase via the Digital Marketplace, offering a large pool of captive buyers for suppliers.

 

I don't know how to do charts (people keep mentioning RSI and MACD so if someone cam explain that would be useful . However the basic lies that GRC has fallen from 15p to 6p due to unusually large sells makes this appear to be bargain territory

Particularly with the CEO owning 25% and offering unused banking facilities, and where the annual SAAS is worth more than the .current market value

This was from the interims

The Group has banking facilities to provide adequate headroom for unforeseen working capital requirements by way of an invoice discounting facility.

In addition, the unsecured loan facility provided by Andrew Brode for the amount of £700,000 at an interest rate of 5% above the Bank of England base rate to provide additional working capital is available to the Company until at least 31 December 2023 and shall automatically renew for a further 12 months unless terminated by either party. As at the period end and the date of this report £350,000 remained available to be drawn down

This is from the article referenced

August 10, 2023

AI is essential for the future of drug discovery and development

GlobalData Healthcare

It is hoped that AI can revolutionise the drug discovery process and significantly reduce the time and cost of getting a drug to market.

Thanks Kidlington

Exploring #AI's capacity to reshape #drugdiscovery and expedite the journey from lab to market. At

@Physiomics

, we are deeply engaged in cutting-edge computational techniques that inform decision-making & accelerate the #drugdevelopment process.

Amd there it appears

Yes, these buys below 6pence won't last long

The annual recurring revenues are now worth more than the business...this is ludicrous

The price action suggests the last of the sell is being worked

I have added

All I can fund is that they have operations in Brazil but nothing about expanding ?

Ouvidor is also home to an Anglo American phosphates mine. The company is now the second largest integrated phosphate fertilizer producer in Brazil, producing nearly six million tonnes of ore per annum. At current production rates, phosphates will continue to be shipped from the site for the next 40 years. Further expansion is planned through the Goiás II project too, which will involve searching for new phosphate rock reserves in the area.

The decade ahead promises much for Minas-Rio as well, when the first iron ore shipment is expected in 2014. Initial production will be 26.5 million tonnes of iron ore per year, potentially rising to up to 90 million tonnes in the future, should expansion be approved

Have you got a link to this please ?

Please could someone help explain what these assets may be ..is it equipment amd land

The net assets of the Group at 31 December 2022 were $9,713,742 (31 December 2021: $8,612,280) and its cash position was $2,723,509 (31 December 2021: $1,708,001).

 

Moving upwards now,I have added more

I had no idea how bad it was and how much money it take s to get a drug to market

Physiomics (AIM:PYC) is a computational systems biology services company applying simulations of cell behaviour to drug development to reduce the high attrition rates of clinical trials. As 80-90 per cent of all clinical drug candidates fail to reach the market, estimates1 show that an overall ten per cent improvement in success rates could reduce the cost of one drug’s development by as much as $242 million, from the current estimate of around $800 million. Physiomics develops computational systems biology models to predict and understand cancer drug

efficacy from pre-clinical research to clinical development

I have taken my profits from my purchases earlier in the week

Have a good weekend

L

I have purchased my first investment amd will look to add more

Thanks for the advice from everyone

HMI looks like it could have a SENX type bounce